-
Product Insights
NewYellow Fever – Drugs In Development, 2024
Empower your strategies with our Yellow Fever – Drugs In Development, 2024 report and make more profitable business decisions. Yellow fever is an acute systemic illness (hemorrhagic fever) caused by a flavivirus. It is spread by mosquitoes. Symptoms include irregular heartbeat, bleeding, vomiting, coma, delirium, fever, headache, and muscle aches. There is no specific treatment for yellow fever, so patients are treated to relieve the symptoms. The Yellow Fever drugs in development market research report provide comprehensive information on the therapeutics...
-
Product Insights
NewHaemophilus influenzae Type B Infections – Drugs In Development, 2024
Empower your strategies with our Haemophilus influenzae Type B Infections – Drugs In Development, 2024 report and make more profitable business decisions. Haemophilus influenzae type B (Hib) is a bacterium that causes an infection that can lead to serious or life-threatening illness, especially in children. Symptoms include severe headache, stiff neck, convulsions or seizures, severe drowsiness, difficulty waking up, loss of consciousness, or difficulty breathing. Predisposing factors include age and weakened immune system. Treatment includes antibiotics. The Haemophilus influenzae Type B...
-
Product Insights
NewHelicobacter pylori Infections – Drugs In Development, 2024
Empower your strategies with our Helicobacter pylori Infections – Drugs In Development, 2024 report and make more profitable business decisions. Helicobacter pylori (H. pylori) infection occurs when the Helicobacter pylori (H. pylori) bacteria infect the stomach, typically during childhood. A leading cause of stomach ulcers, this infection is asymptomatic for many, with over half of the global population potentially affected. Recognition often arises when peptic ulcer symptoms manifest, prompting healthcare providers to test for H. pylori. Peptic ulcers, affecting the stomach...
-
Product Insights
NewHepatitis D – Drugs In Development, 2024
Empower your strategies with our Hepatitis D – Drugs In Development, 2024 report and make more profitable business decisions. Hepatitis D, also known as the delta virus, is an infection that causes the liver to swell. It is caused by the hepatitis D virus (HDV). Symptoms include yellowing of skin and eyes, joint pain, abdominal pains, vomiting, loss of appetite, and fatigue. Risk factors include receiving many blood transfusions, abusing intravenous (IV) or injection drugs, and being infected while pregnant. The...
-
Product Insights
NewLassa Fever (Lassa Hemorrhagic Fever) – Drugs In Development, 2024
Empower your strategies with our Lassa Fever (Lassa Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Lassa fever is an acute viral hemorrhagic illness caused by Lassa virus, a member of the arenavirus family of viruses. It is transmitted to humans from contacts with food or household items contaminated with rodent excreta. Symptoms include fever, headache, chills, back pain, weight loss, swollen neck, rashes, and bleeding. The antiviral drug ribavirin seems to be an effective...
-
Product Insights
NewLyme Disease – Drugs In Development, 2024
Empower your strategies with our Lyme Disease – Drugs In Development, 2024 report and make more profitable business decisions. Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches, and headache. Risk factors include age, gender, and geographic location. Treatment includes antibiotics. The Lyme Disease drugs in development market research report provide comprehensive information on the therapeutics under development for Lyme Disease, complete with...
-
Product Insights
NewNeisseria gonorrhoeae Infections – Drugs In Development, 2024
Empower your strategies with our Neisseria gonorrhoeae Infections – Drugs In Development, 2024 report and make more profitable business decisions. Neisseria gonorrhoeae, the bacterium accountable for the sexually transmitted infection (STI) gonorrhea, is a notable public health issue causing substantial global morbidity in both resource-rich and resource-poor nations. The diagnosis and treatment of this infection entail considerable financial expenditures each year. Similar to other sexually transmitted infections (STIs), gonorrhea has a disproportionate impact on young adults. The obligate human pathogen N....
-
Product Insights
NewPandemic Influenza – Drugs In Development, 2024
Empower your strategies with our Pandemic Influenza – Drugs In Development, 2024 report and make more profitable business decisions. A flu pandemic is characterized by the worldwide spread of a novel flu A virus, and it occurs when this emerging virus has the capability to efficiently infect and transmit among humans, affecting a large population with limited immunity. Such pandemics are marked by the ability of the new influenza A virus to spread easily from person to person. The most recent...
-
Product Insights
NewBacillary Dysentery (Shigellosis) – Drugs In Development, 2024
Empower your strategies with our Bacillary Dysentery (Shigellosis) – Drugs In Development, 2024 report and make more profitable business decisions. Shigella infection (shigellosis) is an intestinal disease caused by bacteria known as shigella. Symptoms include diarrhea, abdominal cramps, and fever. Predisposing factors include eating contaminated food, age, international travel, and being a homosexual man. Treatment includes antibiotics. The Bacillary Dysentery (Shigellosis) drugs in development market research report provide comprehensive information on the therapeutics under development for Bacillary Dysentery (Shigellosis), complete with...
-
Product Insights
NewMeningitis – Drugs In Development, 2024
Empower your strategies with our Meningitis – Drugs In Development, 2024 report and make more profitable business decisions. Meningitis is the inflammation of the meninges, protective membranes covering the brain and spinal cord. The cause of inflammation can be infection by viruses, bacteria, or other microorganisms, and less commonly by certain drugs. As the inflammation is in proximity to the brain and spinal cord, meningitis can be life-threatening, depending on its cause. Viral meningitis is not life-threatening; those affected can be...